GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » EV-to-Revenue

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) EV-to-Revenue : 11.22 (As of Jul. 19, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Beijing Aosaikang Pharmaceutical Co's enterprise value is ¥20,612 Mil. Beijing Aosaikang Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,838 Mil. Therefore, Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue for today is 11.22.

The historical rank and industry rank for Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SZSE:002755' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.14   Med: 3.79   Max: 34.84
Current: 11.22

During the past 13 years, the highest EV-to-Revenue of Beijing Aosaikang Pharmaceutical Co was 34.84. The lowest was 0.14. And the median was 3.79.

SZSE:002755's EV-to-Revenue is ranked worse than
87.59% of 967 companies
in the Drug Manufacturers industry
Industry Median: 2.57 vs SZSE:002755: 11.22

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-19), Beijing Aosaikang Pharmaceutical Co's stock price is ¥25.81. Beijing Aosaikang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥2.05. Therefore, Beijing Aosaikang Pharmaceutical Co's PS Ratio for today is 12.57.


Beijing Aosaikang Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Aosaikang Pharmaceutical Co EV-to-Revenue Chart

Beijing Aosaikang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.83 3.27 3.13 5.90 5.54

Beijing Aosaikang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.24 4.37 5.38 5.54 7.96

Competitive Comparison of Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue falls into.


;
;

Beijing Aosaikang Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=20611.750/1837.705
=11.22

Beijing Aosaikang Pharmaceutical Co's current Enterprise Value is ¥20,612 Mil.
Beijing Aosaikang Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,838 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Aosaikang Pharmaceutical Co  (SZSE:002755) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Beijing Aosaikang Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=25.81/2.053
=12.57

Beijing Aosaikang Pharmaceutical Co's share price for today is ¥25.81.
Beijing Aosaikang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Aosaikang Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Aosaikang Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Aosaikang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070
Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.
Executives
Wang Zheng Yong Executives
Li Xiao Xin Supervisors
Ren Wei Rong Directors, executives
Chen Qing Cai Directors, Directors, and Executives
Du Chao Yang Executives
Ma Yao Chuan Director
Wu Zhan Feng Supervisors
Guo Hong Jie Director

Beijing Aosaikang Pharmaceutical Co Headlines

No Headlines